Ibuprofen API Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Ibuprofen API Market in 2025 is evaluated at USD 727.67 million. The global Market size was more than USD 715.08 million in 2024 and is anticipated to grow at a CAGR of around 2.2%, reaching USD 948.89 million revenue by 2037. Asia Pacific is expected to yield USD 332.11 million by 2037, driven by low manufacturing cost of medicines and increasing health expenditure in the region.
The growth of the market is poised to be dominated by a surge in prevalence of influenza. For instance, according to the prediction of WHO every year, there are approximately a billion instances of seasonal influenza, with 3–5 million of those instances resulting in serious disease. Hence, ibuprofen API used with a mixture of acetaminophen is set to be increased to tackle this issue. These medications can relieve headaches and muscle aches in addition to lowering temperature.
Additionally, the rise in COVID-19 cases is also projected to have a great influence on the ibuprofen API market over the coming years. Despite being primarily a respiratory illness, COVID-19 may demand a long time to be identified and require self-administered symptomatic treatment of its subtle and non-specific clinical course. Since one of the most typical signs of COVID-19 is fever, antipyretic drugs like ibuprofen are crucial for managing patients' symptoms.
